These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16897850)

  • 1. [Clinical significance of non-ACE-dependent angiotensin II-forming system].
    Urata H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():27-33. PubMed ID: 16897850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tissue angiotensin II generating system].
    Miyazaki M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():57-62. PubMed ID: 16895169
    [No Abstract]   [Full Text] [Related]  

  • 3. [involvement of chymase in pathogenesis of cardiovascular diseases].
    Urata H
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():147-51. PubMed ID: 15171359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diversity in mechanism of angiotensin II production and application of the suppressive agents].
    Miyazaki T
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):178-9. PubMed ID: 18421843
    [No Abstract]   [Full Text] [Related]  

  • 5. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
    Liao Y; Husain A
    Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiological roles of human chymase].
    Nakayama S; Urata H; Arakawa K
    Nihon Rinsho; 1997 Aug; 55(8):1903-8. PubMed ID: 9284400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor suppressive effect].
    Takai S; Miyazaki M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():512-7. PubMed ID: 16895220
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
    Li M; Liu K; Michalicek J; Angus JA; Hunt JE; Dell'Italia LJ; Feneley MP; Graham RM; Husain A
    J Clin Invest; 2004 Jul; 114(1):112-20. PubMed ID: 15232618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms?
    Kokkonen JO; Lindstedt KA; Kovanen PT
    Circulation; 2003 May; 107(20):2522-4. PubMed ID: 12777313
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
    Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
    Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of angiotensin II-forming enzymes, angiotensin-converting enzyme and chymase].
    Takai S; Miyazaki M
    Nihon Rinsho; 1999 May; 57(5):1078-83. PubMed ID: 10361438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
    Urata H; Ganten D
    Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
    Husain A; Li M; Graham RM
    Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
    [No Abstract]   [Full Text] [Related]  

  • 14. Chymase: a new pharmacologic target in cardiovascular disease.
    Bacani C; Frishman WH
    Cardiol Rev; 2006; 14(4):187-93. PubMed ID: 16788331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
    Nickenig G; Ostergren J; Struijker-Boudier H
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S1-7. PubMed ID: 16969748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chymase-dependent angiotensin II-formation].
    Urata H
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():60-4. PubMed ID: 15813045
    [No Abstract]   [Full Text] [Related]  

  • 17. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA
    Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases.
    Urata H; Nishimura H; Ganten D; Arakawa K
    Blood Press Suppl; 1996; 2():22-8. PubMed ID: 8913536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
    Dell'Italia LJ; Husain A
    Curr Opin Cardiol; 2002 Jul; 17(4):374-9. PubMed ID: 12151872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
    Johnston CI
    Blood Press Suppl; 2000; 1():9-13. PubMed ID: 11059629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.